It has been widely used to detect druggable tumor-specific genes such as EGFR, ALK, ROS1, BRAF, KRAS, NTRK1/2/3, ERBB2, RET, and MET in patients with NSCLC [7,8]. This evidence concerns the gene ALK and non-small cell lung carcinoma.